Brief: Nanobiotix To Introduce Vision For Transforming Drug Design And Development With Next Nanotherapeutic Platform On 19 December 2024
17/12/2024 21:58
Dec 17 (Reuters) - Nanobiotix SA NANOB.PA :
* NANOBIOTIX TO INTRODUCE VISION FOR TRANSFORMING DRUG
DESIGN AND
DEVELOPMENT WITH NEXT NANOTHERAPEUTIC PLATFORM ON 19 DECEMBER
2024
Source text: ID:nGNX7VTWqd
Further company coverage: NANOB.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nanobiotix SA
See all newsBrief: Nanobiotix S.A. H1 Net Income EUR -34.3 Million
France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gain
Brief: Nanobiotix Reports Encouraging Full Phase 1 Results For Lung Cancer Drug JNJ-1900
Brief: Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln
Brief: NANOBIOTIX Announces Closing Of Global Offering